Your browser doesn't support javascript.
loading
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.
Lee, Leo Y; Zhou, Jie; Koszalka, Paulina; Frise, Rebecca; Farrukee, Rubaiyea; Baba, Keiko; Miah, Shahjahan; Shishido, Takao; Galiano, Monica; Hashimoto, Takashi; Omoto, Shinya; Uehara, Takeki; Mifsud, Edin J; Collinson, Neil; Kuhlbusch, Klaus; Clinch, Barry; Wildum, Steffen; Barclay, Wendy S; Hurt, Aeron C.
Afiliação
  • Lee LY; WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Zhou J; Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • Koszalka P; WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Frise R; Biomedicine Discovery Institute & Department of Microbiology, Monash University, Victoria, Australia.
  • Farrukee R; Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • Baba K; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, Australia.
  • Miah S; Shionogi & Co., Ltd, Osaka, Japan.
  • Shishido T; Public Health England, London, United Kingdom.
  • Galiano M; Shionogi & Co., Ltd, Osaka, Japan.
  • Hashimoto T; Francis Crick Institute, London, United Kingdom.
  • Omoto S; Shionogi & Co., Ltd, Osaka, Japan.
  • Uehara T; Shionogi & Co., Ltd, Osaka, Japan.
  • Mifsud EJ; Shionogi & Co., Ltd, Osaka, Japan.
  • Collinson N; WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Kuhlbusch K; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, Australia.
  • Clinch B; Roche Products Ltd, Welwyn Garden City, United Kingdom.
  • Wildum S; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Barclay WS; Roche Products Ltd, Welwyn Garden City, United Kingdom.
  • Hurt AC; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
PLoS Pathog ; 17(5): e1009527, 2021 05.
Article em En | MEDLINE | ID: mdl-33956888
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Vírus da Influenza A / Piridonas / Triazinas / Replicação Viral / Morfolinas / Infecções por Orthomyxoviridae / Farmacorresistência Viral / Dibenzotiepinas / Modelos Animais de Doenças Tipo de estudo: Evaluation_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Vírus da Influenza A / Piridonas / Triazinas / Replicação Viral / Morfolinas / Infecções por Orthomyxoviridae / Farmacorresistência Viral / Dibenzotiepinas / Modelos Animais de Doenças Tipo de estudo: Evaluation_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos